NXTS is Nexentis Technologies Inc. (Basic Materials) — a non-dividend-paying stock. Trading at $1.68. Market cap: $2M.
Stock snapshot
| Price | $1.68 |
| Market cap | $2M |
| Sector | Basic Materials |
| Exchange | NCM |
| Pays dividend | No |
About NXTS
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Related non-dividend companies
Other non-dividend stocks investors research alongside NXTS. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is NXTS's current stock price?
NXTS (Nexentis Technologies Inc.) is currently trading at $1.68.
Does NXTS pay a dividend?
NXTS (Nexentis Technologies Inc.) does not currently pay a regular dividend.
Track NXTS in DiviDrip
Add NXTS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search NXTS and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.